MPC-6827

DRUG2 trials

Sponsors

Myrexis Inc.

Conditions

Brain NeoplasmsRefractory Solid Tumors

Phase 1

Multiple Dose Study of MPC-6827 in Subjects With Refractory Brain Metastases

CompletedNCT00393965

Myrexis Inc.Brain Neoplasms

Start: 2005-12-31End: 2008-02-29Updated: 2008-02-13

Phase 1, Multiple Dose Study of MPC-6827 in Subjects With Refractory Solid Tumors

CompletedNCT00394446

Myrexis Inc.Refractory Solid Tumors

Start: 2005-03-31End: 2008-02-29Updated: 2008-02-13